**Chapter 5**

*Translational Research in Cancer*

BMC Med. 2014;12:97.

2008;1(6):502-18.

studies: genetic heterogeneity and individual predisposition to cancer. Trends Genet. 2010;26:132-41.

[54] St Laurent G, Vyatkin Y, Kapranov P. Dark matter RNA illuminates the puzzle of genome-wide association studies.

[55] Parker NR, Khong P, Parkinson JF et al. Molecular heterogeneity in glioblastoma: potential clinical implications. Front Oncol. 2015;5:55.

[56] Schrohl AS, Würtz S, Kohn E et al. Banking of biological fluids for studies of disease-associated protein biomarkers. Molecular & Cellular Proteomics. 2008;7(10):2061-6.

[57] Fredolini C, Meani F, Reeder KA et al. Concentration and preservation of very low abundance biomarkers in urine, such as human growth hormone (hGH), by Cibacron Blue F3G-A loaded hydrogel particles. Nano research.

[58] Luchini A, Geho DH, Bishop B et al. Smart hydrogel particles: biomarker harvesting: one-step affinity purification, size exclusion, and protection against degradation. Nano

letters. 2008;8(1):350-61.

**74**
